Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Weingartner

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
Psychopharmacology|January 1, 1989
Low-dose oral lorazepam administration in Alzheimer subjects and age-matched controlsT Sunderland, H Weingartner, R M Cohen, et al.
The Journal of Nervous and Mental Disease|November 1, 1981
Behavioral and cognitive effects of caffeine in boys and adult malesJ L Rapoport, M Jensvold, R Elkins, et al.
Biological Psychiatry|May 15, 1993
Steroid modulation of human memory: biochemical correlatesO M Wolkowitz, H Weingartner, D R Rubinow, et al.
Neurology|March 1, 1987
Dementia of the Alzheimer type: clinical and family study of 22 twin pairsL E Nee, R Eldridge, T Sunderland, et al.
Plos One|May 23, 2014
Voluntary enhancement of neural signatures of affiliative emotion using FMRI neurofeedbackJorge Moll, Julie H Weingartner, Patricia Bado, et al.
Archives of General Psychiatry|May 1, 1987
L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibitionP N Tariot, R M Cohen, T Sunderland, et al.
Journal of Clinical Pharmacology|April 1, 1996
Human pharmacokinetics and tolerability of L-365,260, a novel cholecystokinin-B antagonistK Grasing, M G Murphy, J Lin, et al.
Psychiatry Research|September 1, 1984
The Genain Quadruplets: psychological studiesA F Mirsky, L E DeLisi, M S Buchsbaum, et al.
Biological Psychiatry|February 1, 1997
Dehydroepiandrosterone (DHEA) treatment of depressionO M Wolkowitz, V I Reus, E Roberts, et al.
Neuroimage. Clinical|September 11, 2019
Blame-rebalance fMRI neurofeedback in major depressive disorder: A randomised proof-of-concept trialRoland Zahn, Julie H Weingartner, Rodrigo Basilio, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
Psychopharmacology|January 1, 1989
Low-dose oral lorazepam administration in Alzheimer subjects and age-matched controlsT Sunderland, H Weingartner, R M Cohen, et al.
The Journal of Nervous and Mental Disease|November 1, 1981
Behavioral and cognitive effects of caffeine in boys and adult malesJ L Rapoport, M Jensvold, R Elkins, et al.
Biological Psychiatry|May 15, 1993
Steroid modulation of human memory: biochemical correlatesO M Wolkowitz, H Weingartner, D R Rubinow, et al.
Neurology|March 1, 1987
Dementia of the Alzheimer type: clinical and family study of 22 twin pairsL E Nee, R Eldridge, T Sunderland, et al.
Plos One|May 23, 2014
Voluntary enhancement of neural signatures of affiliative emotion using FMRI neurofeedbackJorge Moll, Julie H Weingartner, Patricia Bado, et al.
Archives of General Psychiatry|May 1, 1987
L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibitionP N Tariot, R M Cohen, T Sunderland, et al.
Journal of Clinical Pharmacology|April 1, 1996
Human pharmacokinetics and tolerability of L-365,260, a novel cholecystokinin-B antagonistK Grasing, M G Murphy, J Lin, et al.
Psychiatry Research|September 1, 1984
The Genain Quadruplets: psychological studiesA F Mirsky, L E DeLisi, M S Buchsbaum, et al.
Biological Psychiatry|February 1, 1997
Dehydroepiandrosterone (DHEA) treatment of depressionO M Wolkowitz, V I Reus, E Roberts, et al.
Neuroimage. Clinical|September 11, 2019
Blame-rebalance fMRI neurofeedback in major depressive disorder: A randomised proof-of-concept trialRoland Zahn, Julie H Weingartner, Rodrigo Basilio, et al.
Pageof 16